Zhu Kun, Whitehouse Andrew J O, Hart Prue H, Kusel Merci, Mountain Jenny, Lye Stephen, Pennell Craig, Walsh John P
Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Australia; School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia.
J Bone Miner Res. 2014;29(5):1088-95. doi: 10.1002/jbmr.2138.
It is uncertain whether the vitamin D status of pregnant women influences bone mass of their children. Cohort studies have yielded conflicting results; none have examined offspring at skeletal maturity. This longitudinal, prospective study investigated the association between maternal vitamin D status and peak bone mass of offspring in 341 mother and offspring pairs in the Western Australian Pregnancy Cohort (Raine) Study. Maternal serum samples collected at 18 weeks gestation were assayed for 25-hydroxyvitamin D (25OHD). Outcomes were total body bone mineral content (BMC) and bone mineral density (BMD) measured by dual-energy X-ray absorptiometry in offspring at 20 years of age. The mean (± SD) maternal serum 25OHD concentration was 57.2 ± 19.2 nmol/L; 132 women (38.7%) were vitamin D-deficient (25OHD <50 nmol/L). After adjustment for season of sample collection, maternal factors, and offspring factors (sex, birth weight, and age, height, lean mass, and fat mass at 20 years), maternal 25OHD concentration was positively associated with total body BMC and BMD in offspring, with a mean difference of 19.2 (95% confidence interval [CI], 5.6-32.7) g for BMC and 4.6 (95% CI, 0.1-9.1) mg/cm(2) for BMD per 10.0 nmol/L of maternal 25OHD. Maternal vitamin D deficiency was associated with 2.7% lower total body BMC (mean ± SE) (2846 ± 20 versus 2924 ± 16 g, p = 0.004) and 1.7% lower total body BMD (1053 ± 7 versus 1071 ± 5 mg/cm(2) , p = 0.043) in the offspring. We conclude that vitamin D deficiency in pregnant women is associated with lower peak bone mass in their children. This may increase fracture risk in the offspring in later life.
孕妇的维生素D状态是否会影响其子女的骨量尚不确定。队列研究得出了相互矛盾的结果;尚无研究在骨骼成熟时对后代进行检查。这项纵向前瞻性研究在西澳大利亚妊娠队列(Raine)研究中的341对母婴中,调查了母亲维生素D状态与后代峰值骨量之间的关联。在妊娠18周时采集的母亲血清样本检测了25-羟基维生素D(25OHD)。结局指标是后代20岁时通过双能X线吸收法测量的全身骨矿物质含量(BMC)和骨矿物质密度(BMD)。母亲血清25OHD浓度的平均值(±标准差)为57.2±19.2 nmol/L;132名女性(38.7%)维生素D缺乏(25OHD<50 nmol/L)。在对样本采集季节、母亲因素和后代因素(性别、出生体重以及20岁时的年龄、身高、瘦体重和脂肪量)进行校正后,母亲25OHD浓度与后代的全身BMC和BMD呈正相关,每10.0 nmol/L母亲25OHD,BMC的平均差异为19.2(95%置信区间[CI],5.6 - 32.7)g,BMD的平均差异为4.6(95%CI,0.1 - 9.1)mg/cm²。母亲维生素D缺乏与后代全身BMC降低2.7%(平均值±标准误)(2846±20对2924±16 g,p = 0.004)和全身BMD降低1.7%(1053±7对1071±5 mg/cm²,p = 0.043)相关。我们得出结论,孕妇维生素D缺乏与子女较低的峰值骨量相关。这可能会增加后代晚年发生骨折的风险。